Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 04, 2025
Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinib.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 13, 2024
Single-Institution Experience of Larotrectinib Therapy for Patients With NTRK Fusion-Positive Thyroid Carcinoma.
Journal: Journal of the Endocrine Society
Published: June 20, 2024
Showing 1-3 of 3
Last Updated: 09/26/2026